Any feedback?
Literature summary for 3.4.24.75 extracted from
- Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin (2009), Pediatr. Res., 65, 420-424.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Staphylococcus simulans | - |
- |
- |
Specific Activity [micromol/min/mg]
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| additional information | - |
FVB albino dams infected with methicillin-resistant Staphylococcus aureus for analysis of lysostaphin impact on pharmacokinetics, minimum inhibitory concentration(0.008 microg/ml) and minimum bactericidal concentration (0.015 microg/ml) | Staphylococcus simulans |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| lysostaphin | - |
Staphylococcus simulans |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
